Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer

Li,Chengyun; Liang,Geyu; Yao,Wenzhuo; Sui,Jing; Shen,Xian; Zhang,Yanqiu; Ma,Shumei; Ye,Yancheng; Zhang,Zhiyi; Zhang,Wenhua; Yin,Lihong; Pu,Yuepu

doi:10.3892/or.2015.4531

Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer

Authors:
- Chengyun Li
- Geyu Liang
- Wenzhuo Yao
- Jing Sui
- Xian Shen
- Yanqiu Zhang
- Shumei Ma
- Yancheng Ye
- Zhiyi Zhang
- Wenhua Zhang
- Lihong Yin
- Yuepu Pu
View Affiliations

Affiliations: Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, P.R. China, Gansu Wuwei Tumor Hospital, Wuwei, Gansu 733000, P.R. China
Published online on: December 29, 2015 https://doi.org/10.3892/or.2015.4531
Pages: 1529-1540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) is one of the most lethal malignancies worldwide. To reduce its high mortality, sensitive and specific biomarkers for early detection are urgently needed. Recent studies have reported that tumor-specific long non-coding RNAs (lncRNAs) seem to be potential biomarkers for the early diagnosis and treatment of cancer. In the present study, lncRNA and mRNA expression profiling of GC specimens and their paired adjacent non-cancerous tissues was performed. Differentially expressed lncRNAs and mRNAs were identified through microarray analysis. The function of differential mRNA was determined by gene ontology and pathway analysis and the functions of lncRNAs were studied by constructing a co-expression network to find the relationships with corresponding mRNAs. We connected the co-expression network, mRNA functions, and the results of the microarray profile differential expression and selected 14 significantly differentially expressed key lncRNAs and 21 key mRNAs. Quantitative RT-PCR (qRT-PCR) was conducted to verify these key RNAs in 50 newly diagnosed GC patients. The data showed that RP5-919F19, CTD-2541M15 and UCA1 was significantly higher expressed. AP000459, LOC101928316, RP11-167N4 and LINC01071 expression was significantly lower in 30 advanced GC tumor tissues than adjacent non-tumor tissues P<0.05. Then, we further validated the above significant differential expression candidate lncRNAs in 20 early stage GC patients. Results showed that CTD-2541M15 and UCA1 were significantly higher expressed, AP000459, LINC01071 and MEG3 expression was significantly lower in 20 early stage GC patient tumor tissues than adjacent non-tumor tissues (P<0.05). In addition, expression of these lncRNAs shows gradual upward trend from early stage GC to advanced GC. Furthermore, conditional logistic regression analysis revealed the aberrant expression of CTD-2541M15, UCA1 and MEG3 closely linked with GC. There is a set of differentially expressed lncRNAs in GC which may be associated with the progression and development of GC. The differential expression profiles of lncRNAs in GC may be promising biomarkers for the early detection and early screening of high‑risk populations.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
3	Tanaka N, Katai H, Taniguchi H, Saka M, Morita S, Fukagawa T and Gotoda T: Trends in characteristics of surgically treated early gastric cancer patients after the introduction of gastric cancer treatment guidelines in Japan. Gastric Cancer. 13:74–77. 2010. View Article : Google Scholar : PubMed/NCBI
4	Kurella RR, Ancha HR, Ancha HB, Lightfoot SA, Guild RT and Harty RF: Obscure GI bleeding due to gastrointestinal stromal tumor (GIST) diagnosed by capsule endoscopy. J Okla State Med Assoc. 101:35–37. 2008.PubMed/NCBI
5	Cheetham SW, Gruhl F, Mattick JS and Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
6	Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: Insights into functions. Nat Rev Genet. 10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
7	Tsai MC, Spitale RC and Chang HY: Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
8	He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar
9	Hung T and Chang HY: Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585. 2010. View Article : Google Scholar : PubMed/NCBI
10	Song W, Liu YY, Peng JJ, Liang HH, Chen HY, Chen JH, He WL, Xu JB, Cai SR and He YL: Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer. J Gastroenterol. Jun 5–2015.Epub ahead of print. PubMed/NCBI
11	Zhang T, Jiang M, Chen L, Niu B and Cai Y: Prediction of gene phenotypes based on GO and KEGG pathway enrichment scores. Biomed Res Int. 2013:8707952013.PubMed/NCBI
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
13	Vu HL, Troubetzkoy S, Nguyen HH, Russell MW and Mestecky J: A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis. Nucleic Acids Res. 28:E182000. View Article : Google Scholar : PubMed/NCBI
14	Li X, Chen H, Li J and Zhang Z: Gene function prediction with gene interaction networks: A context graph kernel approach. IEEE Trans Inf Technol Biomed. 14:119–128. 2010. View Article : Google Scholar
15	Zhao Z, Han F, Yang S, Wu J and Zhan W: Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: Involvement of the Akt-mTOR signaling pathway. Cancer Lett. 358:17–26. 2015. View Article : Google Scholar
16	Vilkin A, Levi Z, Morgenstern S, Shmuely H, Gal E, Hadad B, Hardi B and Niv Y: Higher gastric mucin secretion and lower gastric acid output in first-degree relatives of gastric cancer patients. J Clin Gastroenterol. 42:36–41. 2008. View Article : Google Scholar
17	Li H, Yu B, Li J, Su L, Yan M, Zhang J, Li C, Zhu Z and Liu B: Characterization of differentially expressed genes involved in pathways associated with gastric cancer. PLoS One. 10:e01250132015. View Article : Google Scholar : PubMed/NCBI
18	Carlson MR, Zhang B, Fang Z, Mischel PS, Horvath S and Nelson SF: Gene connectivity, function, and sequence conservation: Predictions from modular yeast co-expression networks. BMC Genomics. 7:402006. View Article : Google Scholar : PubMed/NCBI
19	Songun I, Putter H, Kranenbarg EM, Sasako M and van de Velde CJ: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 11:439–449. 2010. View Article : Google Scholar : PubMed/NCBI
20	Cho JY: Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer. 13:129–135. 2013. View Article : Google Scholar : PubMed/NCBI
21	Cogill SB and Wang L: Co-expression network analysis of human lncRNAs and cancer genes. Cancer Inform. 13(Suppl 5): 49–59. 2014.PubMed/NCBI
22	Wang YY, Ye ZY, Zhao ZS, Tao HQ and Li SG: Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer. J Cancer Res Clin Oncol. 136:135–141. 2010. View Article : Google Scholar
23	Charvat H, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T and Yamaji T: Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: The JPHC study cohort II. Int J Cancer. Jul 28–2015. View Article : Google Scholar : Epub ahead of print. PubMed/NCBI
24	Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O and Ye W: Incidence of gastric cancer among patients with gastric precancerous lesions: Observational cohort study in a low risk Western population. BMJ. 351:h38672015. View Article : Google Scholar : PubMed/NCBI
25	Li M, Qiu M, Xu Y, Mao Q, Wang J, Dong G, Xia W, Yin R and Xu L: Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer. Tumour Biol. Jul 16–2015.Epub ahead of print.
26	Chen X, Sun J, Song Y, Gao P, Zhao J, Huang X, Liu B, Xu H and Wang Z: The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer. Med Oncol. 31:2622014. View Article : Google Scholar : PubMed/NCBI
27	Mizrahi I, Mazeh H, Grinbaum R, Beglaibter N, Wilschanski M, Pavlov V, Adileh M, Stojadinovic A, Avital I, Gure AO, et al: Colon cancer associated transcript-1 (CCAT1) expression in adenocarcinoma of the stomach. J Cancer. 6:105–110. 2015. View Article : Google Scholar : PubMed/NCBI
28	Zhuang M, Gao W, Xu J, Wang P and Shu Y: The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
29	Pan W, Liu L, Wei J, Ge Y, zhang J, Chen H, Zhou L, Yuan Q, Zhou C and Yang M: A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility. Mol Carcinog. Jan 3–2015. View Article : Google Scholar : Epub ahead of print. PubMed/NCBI
30	Sun M, Xia R, Jin F, Xu T, Liu Z, De W and Liu X: Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar
31	Li PF, Chen SC, Xia T, Jiang XM, Shao YF, Xiao BX and Guo JM: Non-coding RNAs and gastric cancer. World J Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
32	Niland CN, Merry CR and Khalil AM: Emerging roles for long Non-Coding RNAs in cancer and neurological disorders. Front Genet. 3:252012. View Article : Google Scholar : PubMed/NCBI
33	Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y: Long non-coding RNA: A new player in cancer. J Hematol Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
34	Wang J, Song YX and Wang ZN: Non-coding RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
35	Wu XM, Shao XQ, Meng XX, Zhang XN, Zhu L, Liu SX, Lin J and Xiao HS: Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells. Acta Pharmacol Sin. 32:259–269. 2011. View Article : Google Scholar : PubMed/NCBI
36	Chen Z, Zhang L, Xia L, Jin Y, Wu Q, Guo H, Shang X, Dou J, Wu K, Nie Y, et al: Genomic analysis of drug resistant gastric cancer cell lines by combining mRNA and microRNA expression profiling. Cancer Lett. 350:43–51. 2014. View Article : Google Scholar : PubMed/NCBI
37	Fan H, Guo Z and Wang C: Combinations of gene ontology and pathway characterize and predict prognosis genes for recurrence of gastric cancer after surgery. DNA Cell Biol. 34:579–587. 2015. View Article : Google Scholar : PubMed/NCBI
38	Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression signatures of bladder cancer revealed by microarray. Oncol Lett. 7:1197–1202. 2014.PubMed/NCBI
39	Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, et al: Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet. 39:1338–1349. 2007. View Article : Google Scholar : PubMed/NCBI
40	Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X and Li X: Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol. 41:276–284. 2012.PubMed/NCBI
41	Yan J, Guo X, Xia J, Shan T, Gu C, Liang Z, Zhao W and Jin S: MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol. 31:8792014. View Article : Google Scholar : PubMed/NCBI
42	Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, Zhou B, Chen JJ and Chen P: Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol. 17:640–646. 2015. View Article : Google Scholar : PubMed/NCBI